Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs SELLAS Life Sciences Group, Inc. (SLS)

Fortrea Holdings Inc. and SELLAS Life Sciences Group, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and SELLAS Life Sciences Group, Inc. are of similar size ($2.3B and $2.2B). SELLAS Life Sciences Group, Inc. has the higher net margin (0.00% vs −3.18%) and the higher return on invested capital (0.00% vs −0.48%). Across the 16 metrics below, Fortrea Holdings Inc. leads on 8 and SELLAS Life Sciences Group, Inc. on 8.

Valuation

Metric FTRE SLS Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 179.81 9.71
P/B 4.07 13.72 2.13
Price to free cash flow 10.77 n/m 20.82
EV/EBITDA 44.71 n/m 0.64
EV/Sales 1.13 166.67 9.21
Earnings yield (4.05%) (2.10%) (33.15%)
Free cash flow yield 9.29% (2.04%) (25.50%)

Profitability

Metric FTRE SLS Biotechnology median
Gross margin 19.30% 0.00% 65.16%
Operating margin (0.40%) 0.00% 0.00%
Net margin (3.18%) 0.00% 0.00%
Free cash flow margin 7.40% 0.00% 0.00%
Return on equity (15.30%) (39.63%) (56.36%)
Return on assets (3.07%) (36.54%) (48.04%)
Return on invested capital (0.48%) 0.00% 0.00%

Growth

Metric FTRE SLS Biotechnology median
Revenue growth (TTM) (2.09%) — 6.02%
EPS growth (last fiscal year) (194.55%) 50.00% 30.26%
Revenue growth, 5-year CAGR 1.09% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE SLS Biotechnology median
Debt to equity 2.01 0.00 0.00
Current ratio 0.96 18.83 4.72
Net debt to EBITDA 266.13 2.54 0.96

Dividend

Metric FTRE SLS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTRE SLS Biotechnology median
Market cap 2.16b 2.29b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack